Drugs / YPT-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04684641 | Mar 2021 → May 2023 | cystic fibrosis | Yale University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YPT-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04684641 ↗ |
| Modality | Other / unclassified | “phage therapy” NCT04684641 ↗ |
| Route | Inhaled | “inhaled (nebulized) phage therapy YPT-01” NCT04684641 ↗ |